Composite nanovesicles for enhanced chemodynamic cancer therapy via decitabine-mediated epigenetic reactivation
Fields of Study & Subjects
interferon and immune responses
Nanoplatforms for cancer theranostics
Inflammasome and immune disorders
Publication details
- Journal / source
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Volume
- 394
- Pages
- 114849–114849
- Publication date
- 21 March 2026
- Language
- EN